POMASKIN Study: Pomanox® P30 for skin aging, hydration & microbiota

Pomanox® P30, a premium pomegranate extract, has been clinically tested for its skin health benefits. The 12-week, triple-blind, placebo-controlled POMASKIN study demonstrated significant improvements in facial pigmentation, hydration, and elasticity in women aged 30-60. Two dosages were evaluated, both showing benefits with differential effects depending on the dose. Additionally, the study revealed beneficial shifts in both skin and gut microbiota, including increases in Lactobacillus and Bifidobacterium. This session will present key findings, positioning Pomanox® P30 as a multifunctional ingredient for skin aging, beauty from within, and microbiome balance.